Pei Ma
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Inflammasome and immune disorders
Papers in
-
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 2
-
- RNA modifications and cancer 5
- Kruppel-like factors research 3
- Circular RNAs in diseases 2
- Extracellular vesicles in disease 2
- Co-authors
- Yongqian Shu (28 shared papers)Yutian Pan (9 shared papers)Xi Wu (12 shared papers)Yongqian Shu (5 shared papers)Tongpeng Xu (12 shared papers)Wei Li (4 shared papers)Yuan Fang (2 shared papers)Tao Yu (8 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (4 papers)Molecular Therapy — Nucleic Acids (3 papers)Frontiers in Oncology (2 papers)Cell Death and Disease (2 papers)Molecular Cancer (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Pei Ma
63 papers receiving 4.1k citations
Pei Ma's Hit Papers
Peers
Comparison fields: 5 of 89
- Cancer Research 1.1k
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 272
- Infectious Diseases 143
- Nutrition and Dietetics 48
Countries citing papers authored by Pei Ma
This map shows the geographic impact of Pei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Ma more than expected).
Fields of papers citing papers by Pei Ma
This network shows the impact of papers produced by Pei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Ma. The network helps show where Pei Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Pei Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pyroptosis: A new frontier in cancer Hit paper breakdown → | 2019 | 830 |
| 2 | 2020 | 328 | |
| 3 | 2020 | 253 | |
| 4 | 2018 | 250 | |
| 5 | 2015 | 204 | |
| 6 | 2018 | 183 | |
| 7 | 2016 | 151 | |
| 8 | 2018 | 106 | |
| 9 | 2021 | 102 | |
| 10 | 2017 | 95 | |
| 11 | 2020 | 95 | |
| 12 | 2018 | 92 | |
| 13 | 2021 | 87 | |
| 14 | 2017 | 81 | |
| 15 | 2019 | 76 | |
| 16 | 2012 | 75 | |
| 17 | 2015 | 72 | |
| 18 | 2015 | 63 | |
| 19 | 2018 | 61 | |
| 20 | 2022 | 50 |
About Pei Ma
Pei Ma is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Nutrition and Dietetics, having authored 65 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (17 papers), Lung Cancer Treatments and Mutations (5 papers), RNA modifications and cancer (5 papers), Kruppel-like factors research (3 papers), Circular RNAs in diseases (2 papers), MicroRNA in disease regulation (2 papers), Extracellular vesicles in disease (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.3k citations), Pulmonary and Respiratory Medicine (272 citations), Infectious Diseases (143 citations) and Nutrition and Dietetics (48 citations). Pei Ma has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yongqian Shu, Yutian Pan, Xi Wu, Yongqian Shu, Tongpeng Xu, Wei Li, Yuan Fang, Tao Yu, Qiming Wang and Yu Rong Tang. Their work appears in journals such as Biomedicine & Pharmacotherapy, Molecular Therapy — Nucleic Acids, Frontiers in Oncology, Cell Death and Disease and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.